Rare diseases
Investigational molecules
Locations
Back to Spain3 294 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
SpainStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
SpainStudy of RO7126209 safety and effects given by intravenous infusion in patients with early stage or mild to moderate Alzheimer's disease
SpainStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
SpainStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
SpainLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
SpainStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
SpainStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
SpainStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
SpainStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
SpainStudy of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
SpainStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.
Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.
Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.
Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.
Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.
Focus on developing targeted treatments to improve neurological outcomes and patient care.
Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.
Research aims to enhance protection against common and serious infectious diseases.
Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.
Focus on developing more effective and personalized cancer treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
